Synthetic drug could reverse cognitive damage in Alzheimer’s patients, claim researchers

CREDIT: @medlineplus

Synthetic drug could reverse cognitive damage in Alzheimer’s patients, claim researchers.

A NEW study suggests the crippling effects of the disease could be treated with unique synthetic drugs designed to help the brain process proteins.

Almost 35 million people are diagnosed with Alzheimer’s worldwide, and researchers have for many years focused on finding new potential treatments and medical strategies.

But while there is still no cure for the crippling disease, a team of neuroscientists from New York and Brazil believe they may have found a glimmer of hope to repairing some of the damage caused.

Through memory experiments with mice, they have discovered special drugs targeting protein synthesis in the brain could help to restore some of the cognitive function lost or impaired by Alzheimer’s disease.

“This work is the first to show that reversing impaired protein synthesis in brains afflicted by Alzheimer’s disease through a pharmacological approach is not only feasible but also effective,” said Mauricio Martins-Oliveira, lead author of the study and postdoctoral researcher at New York University’s Centre for Neural Science.

Researchers used the synthetic compound known as ISRIB in an experiment involving test mice with Alzheimer’s-like conditions to determine if ISRIB reversed their memory impairments.

And after a series of memory tests and challenges, they found ISRIB had a profound impact on the mice, even in the more advanced cases of Alzheimer’s-like conditions.

Eric Klann, co-senior author on the study and professor at NYU’s Centre for Neural Science said researchers hope their results will act as a significant new tool in the battle against the disease.

“Our findings show that jump-starting protein synthesis in the brain can revive lost cognitive functions. We hope that this work can serve as a step forward in treating this devastating disease”, he said in a report.


Thank you for taking the time to read this news article “Synthetic drug could reverse cognitive damage in Alzheimer’s disease, claim researchers”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Tara Rippin

Tara Rippin is a reporter for Spain’s largest English-speaking newspaper, Euro Weekly News, and is responsible for the Costa Blanca region.
She has been in journalism for more than 20 years, having worked for local newspapers in the Midlands, UK, before relocating to Spain in 1990.
Since arriving, the mother-of-one has made her home on the Costa Blanca, while spending 18 months at the EWN head office in Fuengirola on the Costa del Sol.
She loves being part of a community that has a wonderful expat and Spanish mix, and strives to bring the latest and most relevant news to EWN’s loyal and valued readers.

Share your story with us by emailing [email protected], by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews

Comments


    Leave a comment

    Your email address will not be published.